Back to search

Article

GARD is a pan-cancer predictor of radiation therapy benefit

2020-12-22

Abstract excerpt

<h4>ABSTRACT</h4> <h4>Background</h4> Despite advances in cancer genomics, radiation therapy (RT) is still prescribed based on an empiric one-size-fits-all paradigm. Previously, we proposed a novel algorithm using the genomic adjusted radiation dose (GARD) to personalize RT prescription dose based on the biological effect of a given physical RT dose, calculated using individual tumor genomics. We hypothesize that...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
af696f68-b7be-5e74-a923-612826a672d7
DOI
10.1101/2020.12.19.20248484
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
GARD is a pan-cancer predictor of radiation therapy benefitDOI 10.1101/2020.12.19.20248484
Select a neighboring publication to make it the new centre.